DermTech Inc. (DMTK)
DermTech Statistics
Share Statistics
DermTech has 34.96M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 34.96M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 12.58% |
| Shares Floating | 32.53M |
| Failed to Deliver (FTD) Shares | 25.08K |
| FTD / Avg. Volume | 1.33% |
Short Selling Information
The latest short interest is 3.02M, so 8.64% of the outstanding shares have been sold short.
| Short Interest | 3.02M |
| Short % of Shares Out | 8.64% |
| Short % of Float | 8.81% |
| Short Ratio (days to cover) | 13.45 |
Valuation Ratios
The PE ratio is -0.57 and the forward PE ratio is null. DermTech's PEG ratio is 0.03.
| PE Ratio | -0.57 |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| Forward PS | n/a |
| PB Ratio | 1 |
| P/FCF Ratio | -0.73 |
| PEG Ratio | 0.03 |
Enterprise Valuation
DermTech has an Enterprise Value (EV) of 74.78M.
| EV / Sales | 4.89 |
| EV / EBITDA | -0.76 |
| EV / EBIT | -0.97 |
| EV / FCF | -0.96 |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.95.
| Current Ratio | 4.59 |
| Quick Ratio | 4.52 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | -0.56 |
| Debt / FCF | -0.7 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -176.45% and Return on Invested Capital is -92.98%.
| Return on Equity | -176.45% |
| Return on Assets | -82.74% |
| Return on Invested Capital | -92.98% |
| Revenue Per Employee | $74.25K |
| Profits Per Employee | $-489.75K |
| Employee Count | 206 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 14.96 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -85.39% in the last 52 weeks. The beta is 2.42, so DermTech's price volatility has been higher than the market average.
| Beta | 2.42 |
| 52-Week Price Change | -85.39% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 29.22 |
| Average Volume (20 Days) | 1.89M |
Income Statement
In the last 12 months, DermTech had revenue of 15.3M and earned -100.89M in profits. Earnings per share was -3.09.
| Revenue | 15.3M |
| Gross Profit | 276K |
| Operating Income | -103.74M |
| Net Income | -100.89M |
| EBITDA | -97.89M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.09 |
Balance Sheet
The company has 36.74M in cash and 54.39M in debt, giving a net cash position of -17.65M.
| Cash & Cash Equivalents | 36.74M |
| Total Debt | 54.39M |
| Net Cash | -17.65M |
| Retained Earnings | -423.94M |
| Total Assets | 102.97M |
| Working Capital | 31.68M |
Cash Flow
In the last 12 months, operating cash flow was -76.98M and capital expenditures -902K, giving a free cash flow of -77.88M.
| Operating Cash Flow | -76.98M |
| Capital Expenditures | -902K |
| Free Cash Flow | -77.88M |
| FCF Per Share | -2.39 |
Margins
Gross margin is 1.8%, with operating and profit margins of -678.21% and -659.57%.
| Gross Margin | 1.8% |
| Operating Margin | -678.21% |
| Pretax Margin | -659.57% |
| Profit Margin | -659.57% |
| EBITDA Margin | -639.99% |
| EBIT Margin | -678.21% |
| FCF Margin | -509.16% |
Dividends & Yields
DMTK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -176.62% |
| FCF Yield | -136.34% |
Analyst Forecast
Currently there are no analyst rating for DMTK.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 30, 2019. It was a backward split with a ratio of 1:2.
| Last Split Date | Aug 30, 2019 |
| Split Type | backward |
| Split Ratio | 1:2 |
Scores
| Altman Z-Score | -8.4 |
| Piotroski F-Score | 4 |